Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Augmedix financials data including stock price, CreditSafe score, income statement, balance sheet, cash flow, and acquistions and subsidiaries.
Stock Price
$2.3
2024-10-02
Market Capitalization
$113.3 M
2024-08-26
Revenue
$44.9 M
FY, 2023
CreditSafe Score
?
Score changed on Jul 03, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|---|
| Revenue | 16.5M | 22.2M | 30.9M | 44.9M |
| Cost of goods sold | 9.7M | 12.2M | 17.0M | 23.3M |
| Gross profit | 6.8M | 10.0M | 14.0M | 21.5M |
| Gross profit margin, % | 41.2% | 45.1% | ||
| General and administrative expense | 11.6M | 13.8M | 16.9M | 18.4M |
| Operating expense total | 20.5M | 27.9M | 36.3M | 40.3M |
| EBIT | (13.7M) | (17.9M) | (22.4M) | (18.8M) |
| EBIT margin, % | -83.1% | -80.9% | ||
| Interest income | 10.8K | 15.0K | 245.0K | 1.1M |
| Interest expense | 1.5M | 2.5M | 1.7M | 1.5M |
| Pre tax profit | (24.3M) | (19.0M) | ||
| Income tax expense | 111.0K | 145.0K | ||
| Net Income | (15.6M) | (17.9M) | (24.4M) | (19.2M) |
| EPS | (2.2) | (0.6) |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |